✦ LIBER ✦

Haishengsu as an adjunct therapy to conventional chemotherapy in patients with non-small cell lung cancer: A pilot randomized and placebo-controlled clinical trial

✍ Scribed by Guang-Yao Li; Xiao-Min Yu; Hong-Wei Zhang; Bin Zhang; Chun-Bo Wang; Yan-Chun Xin; Chun-Zheng Yang; Ren-Xiang Zhou; Le-Xin Wang

Book ID: 116394707
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 124 KB
Volume: 17
Category: Article
ISSN: 0965-2299
DOI: 10.1016/j.ctim.2008.10.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Placebo-Controlled Trial of Bexarotene,

Placebo-Controlled Trial of Bexarotene, a Retinoid X Receptor Agonist, as Maintenance Therapy for Patients Treated with Chemotherapy for Advanced Non–Small-Cell Lung Cancer

✍ Naiyer Rizvi; Michael J. Hawkins; Peter D. Eisenberg; Richard C. Yocum; Steven D 📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 138 KB

Psychosocial well being and clinical tox

Psychosocial well being and clinical toxicity in a randomized controlled trial of patients with inoperable non-small cell lung cancer (limited disease)

✍ Thorud, Erik; Kaasa, Stein; Mastekaasa, Arne; Høst, Herman 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Cetuximab-based Therapy is Effective in

Cetuximab-based Therapy is Effective in Chemotherapy-naïve Patients with Advanced and Metastatic Non-small-cell Lung Cancer: A Meta-analysis of Randomized Controlled Trials

✍ Ezzeldin M. Ibrahim; Khaled M. Abouelkhair; Osama A. Al-Masri; Najeeb C. Chaudry 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 295 KB

Comparison of efficacy for postoperative

Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: An early closed randomized controlled trial

✍ Shen, Wen-yi; Ji, Jian; Zuo, Yang-song; Pu, Juan; Xu, Yan-mei; Zong, Cheng-dong; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 445 KB

Randomized Phase III Trial of Erlotinib

Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)

✍ Kawaguchi, T.; Ando, M.; Asami, K.; Okano, Y.; Fukuda, M.; Nakagawa, H.; Ibata, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 183 KB

Randomized Phase II Trial of Erlotinib W

Randomized Phase II Trial of Erlotinib With and Without Entinostat in Patients With Advanced Non-Small-Cell Lung Cancer Who Progressed on Prior Chemotherapy

✍ Witta, S. E.; Jotte, R. M.; Konduri, K.; Neubauer, M. A.; Spira, A. I.; Ruxer, R 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 917 KB